Acceleron Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
Go back to Acceleron Announces Proposed Public Offering of Common Stock
January 6, 2016 6:19 AM EST
Acceleron Pharma Inc. (NASDAQ: XLRN) announced that it has priced an underwritten public offering of 3,750,000 shares of common stock at a price to the public of $40.00 per share for gross proceeds of $150 million. In connection with this offering, Acceleron has granted the underwriters a 30-day option to purchase up to an additional 562,500 shares of common stock.
Morgan Stanley, Leerink Partners LLC and UBS Investment Bank are acting as joint book-running managers for the offering. JMP Securities is acting as the lead manager and FBR is acting as co-manager for the... More
January 5, 2016 7:17 AM EST
Acceleron Pharma (NASDAQ: XLRN) filed a registration with the U.S. SEC to sell up to $300 million worth of its common stock.
...
More
